Incyte Corporation
INCY
$59.61
-$2.50-4.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.13% | 14.76% | 12.94% | 9.78% | 8.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.13% | 14.76% | 12.94% | 9.78% | 8.58% |
| Cost of Revenue | 56.80% | 54.72% | 41.00% | 29.23% | -6.12% |
| Gross Profit | -17.21% | -21.48% | -19.22% | -13.93% | 25.62% |
| SG&A Expenses | 10.59% | 6.92% | 6.08% | 2.56% | 3.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.59% | 36.59% | 33.37% | 24.68% | 2.94% |
| Operating Income | -70.58% | -87.05% | -102.07% | -92.49% | 41.88% |
| Income Before Tax | -69.11% | -62.04% | -57.47% | -37.15% | 99.54% |
| Income Tax Expenses | 7.44% | 20.03% | 10.27% | 32.09% | 46.76% |
| Earnings from Continuing Operations | -97.15% | -94.54% | -92.36% | -73.45% | 129.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.15% | -94.54% | -92.36% | -73.45% | 129.81% |
| EBIT | -70.58% | -87.05% | -102.07% | -92.49% | 41.88% |
| EBITDA | -62.17% | -75.95% | -87.16% | -76.31% | 39.15% |
| EPS Basic | -88.79% | -88.32% | -91.22% | -76.97% | 127.90% |
| Normalized Basic EPS | -50.51% | -64.50% | -75.07% | -62.81% | 55.58% |
| EPS Diluted | -90.36% | -89.87% | -92.52% | -77.73% | 129.38% |
| Normalized Diluted EPS | -52.08% | -65.80% | -75.90% | -63.55% | 55.48% |
| Average Basic Shares Outstanding | -10.98% | -7.39% | -3.74% | -0.03% | 0.72% |
| Average Diluted Shares Outstanding | -10.55% | -7.18% | -3.87% | -0.29% | 0.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |